Pfizer to sell all its patented drugs at nonprofit price to 45 low-income countries
May 25, 2022 Pfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of…
COVID-19 pills are coming, but no substitute for vaccines – Disease experts
Nov. 9, 2021 Oral antiviral pills from Merck & Co and Pfizer Inc/BioNTech SE have been shown to significantly blunt the worst outcomes of COVID-19 if taken early enough, but…
Covid-19: Pfizer, BioNTech say vaccine is safe, trial generates robust immune response in kids ages 5 to 11
Sept. 20, 2021 Pfizer Inc. and BioNTech has announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children 5 to 11…
COVID-19: Pfizer forecasts rise in its 2021 vaccine sales to top $33.5 bn, sees need for boosters
July 29, 2021 Pfizer Inc on Wednesday raised its 2021 sales forecast for its COVID-19 vaccine by 29% to $33.5 billion, and said it believes people will need a third…
UK approves Pfizer-BioNTech vaccine for rollout from next week
Britain on Wednesday became the first Western country to approve a Covid-19 vaccine for general use as it announced a rollout of Pfizer-BioNTech’s vaccine from next week. “The government has…